University of Auckland, School of Biological Sciences, Private Bag 92019, Auckland Mail Centre, Auckland 1142, New Zealand.
Am J Physiol Cell Physiol. 2011 Feb;300(2):C246-55. doi: 10.1152/ajpcell.00294.2010. Epub 2010 Nov 17.
In diabetic cardiomyopathy, ventricular dysfunction occurs in the absence of hypertension or atherosclerosis and is accompanied by altered myocardial substrate utilization and depressed mitochondrial respiration. It is not known if mitochondrial function differs across the left ventricular (LV) wall in diabetes. In the healthy heart, the inner subendocardial region demonstrates higher rates of blood flow, oxygen consumption, and ATP turnover compared with the outer subepicardial region, but published transmural respirometric measurements have not demonstrated differences. We aim to measure mitochondrial function in Wistar rat LV to determine the effects of age, streptozotocin-diabetes, and LV layer. High-resolution respirometry measured indexes of respiration in saponin-skinned fibers dissected from the LV subendocardium and subepicardium of 3-mo-old rats after 1 mo of streptozotocin-induced diabetes and 4-mo-old rats following 2 mo of diabetes. Heart rate and heartbeat duration were measured under isoflurane-anesthesia using a fetal-Doppler, and transmission electron microscopy was employed to observe ultrastructural differences. Heart rate decreased with age and diabetes, whereas heartbeat duration increased with diabetes. While there were no transmural respirational differences in young healthy rat hearts, both myocardial layers showed a respiratory depression with age (30-40%). In 1-mo diabetic rat hearts only subepicardial respiration was depressed, whereas after 2 mo diabetes, respiration in subendocardial and subepicardial layers was depressed and showed elevated leak (state 2) respiration. These data provide evidence that mitochondrial dysfunction is first detectable in the subepicardium of diabetic rat LV, whereas there are measureable changes in LV mitochondria after only 4 mo of aging.
在糖尿病性心肌病中,心室功能障碍发生在没有高血压或动脉粥样硬化的情况下,并伴有心肌底物利用的改变和线粒体呼吸的抑制。目前尚不清楚糖尿病患者左心室(LV)壁的线粒体功能是否存在差异。在健康的心脏中,与外膜下区域相比,内心膜下区域的血流、氧耗和 ATP 周转率更高,但已发表的跨壁呼吸测量并未显示出差异。我们旨在测量 Wistar 大鼠 LV 的线粒体功能,以确定年龄、链脲佐菌素糖尿病和 LV 层的影响。高分辨率呼吸测量法测量了从 LV 心内膜和心外膜分离的皂素处理纤维的呼吸指数,这些纤维来自 3 个月大的大鼠,在链脲佐菌素诱导糖尿病 1 个月后和 4 个月大的大鼠在糖尿病 2 个月后。使用胎儿多普勒在异氟醚麻醉下测量心率和心跳持续时间,并采用透射电子显微镜观察超微结构差异。在年轻健康大鼠心脏中,没有跨壁呼吸差异,但随着年龄的增长,心肌各层都出现了呼吸抑制(30-40%)。在 1 个月糖尿病大鼠心脏中,仅心外膜呼吸受到抑制,而在糖尿病 2 个月后,心内膜和心外膜层的呼吸都受到抑制,并显示出呼吸增强(状态 2)。这些数据提供了证据表明,线粒体功能障碍首先在糖尿病大鼠 LV 的心外膜中是可检测的,而只有 4 个月的衰老就会导致 LV 线粒体发生可测量的变化。